Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Nov 2, 2026.

Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox

Jakob Wirbel, Konrad Zych, Morgan Essex and 6 more

Genome Biology · 2021 · CC BY

doi:10.1101/2020.02.06.931808

Abstract

Supplementary Information. The online version contains supplementary material available at 10.1186/s13059-021-02306-1.

References 113

  1. 1.

    Schmidt TSB, Raes J, Bork P. The human gut microbiome: from association to modulation. Cell. 2018;172:1198-1215.

    Not in our library10.1016/j.cell.2018.02.044

  2. 2.

    Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. Mass Medical Soc; 2016;375:2369–2379.

    Not in our library10.1056/nejmra1600266

  3. 3.

    Garrett WS. The gut microbiota and colon cancer. Science. 2019;364:1133-1135.

    Not in our library10.1126/science.aaw2367

  4. 4.

    Gevers D, Kugathasan S, Denson LA. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe. 2014;15:382–92 Elsevier.

    Not in our library10.1016/j.chom.2014.02.005

  5. 5.

    Franzosa EA, Sirota-Madi A, Avila-Pacheco J, Fornelos N, Haiser HJ, Reinker S, et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019;4:293-305.

    Not in our library10.1038/s41564-018-0306-4

  6. 6.

    Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21:895-905.

    Not in our library10.1038/nm.3914

  7. 7.
    Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis · 2017
    Corrected
  8. 8.
    Potential of fecal microbiota for early‐stage detection of colorectal cancer · 2014
    No notice
  9. 9.

    Tilg H, Cani PD, Mayer EA. Gut microbiome and liver diseases. Gut. 2016;65:2035-2044.

    Not in our library10.1136/gutjnl-2016-312729

  10. 10.

    Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF. The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies. Science. 2018;359:1366-1370.

    Not in our library10.1126/science.aar6918

  11. 11.

    Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015;528:262-266.

    Not in our library10.1038/nature15766

  12. 12.
    Temporal and technical variability of human gut metagenomes · 2015
    No notice
  13. 13.
    Consistent and correctable bias in metagenomic sequencing experiments · 2019
    No notice
  14. 14.
    Metagenomic biomarker discovery and explanation · 2011
    No notice
  15. 15.

    Paulson JN, Stine OC, Bravo HC, Pop M. Differential abundance analysis for microbial marker-gene surveys. Nat Methods. 2013;10:1200-1202.

    Not in our library10.1038/nmeth.2658

  16. 16.

    Mandal S, Van Treuren W, White RA, Eggesbø M, Knight R, Peddada SD. Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb Ecol Health Dis. 2015;26:27663.

    Not in our library10.3402/mehd.v26.27663

  17. 17.

    Knights D, Parfrey LW, Zaneveld J, Lozupone C, Knight R. Human-associated microbial signatures: examining their predictive value. Cell Host Microbe. 2011;10:292-296.

    Not in our library10.1016/j.chom.2011.09.003

  18. 18.

    Knights D, Costello EK, Knight R. Supervised classification of human microbiota. FEMS Microbiol Rev. 2011;35:343-359.

    Not in our library10.1111/j.1574-6976.2010.00251.x

  19. 19.
    Machine Learning Meta-analysis of Large Metagenomic Datasets: Tools and Biological Insights · 2016
    No notice
  20. 20.
    Meta-analysis of gut microbiome studies identifies disease-specific and shared responses · 2017
    No notice
  21. 21.
    Meta-analysis of human genome-microbiome association studies: the MiBioGen consortium initiative · 2018
    No notice
  22. 22.

    Bang S, Yoo D, Kim S-J, Jhang S, Cho S, Kim H. Establishment and evaluation of prediction model for multiple disease classification based on gut microbial data. Sci Rep. 2019;9:10189.

    Not in our library10.1038/s41598-019-46249-x

  23. 23.
    A Review and Tutorial of Machine Learning Methods for Microbiome Host Trait Prediction · 2019
    No notice
  24. 24.

    Le Goallec A, Tierney BT, Luber JM, Cofer EM, Kostic AD, Patel CJ. A systematic machine learning and data type comparison yields metagenomic predictors of infant age, sex, breastfeeding, antibiotic usage, country of origin, and delivery type. PLoS Comput Biol. 2020;16:e1007895.

    Not in our library10.1371/journal.pcbi.1007895

  25. 25.
    Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis · 2013
    No notice
  26. 26.

    Alkanani AK, Hara N, Gottlieb PA, Ir D, Robertson CE, Wagner BD, et al. Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes. Diabetes. 2015;64:3510-3520.

    Not in our library10.2337/db14-1847

  27. 27.

    Nielsen HB, Almeida M, Juncker AS, Rasmussen S, Li J, Sunagawa S, et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat Biotechnol. 2014;32:822-828.

    Not in our library10.1038/nbt.2939

  28. 28.

    Lewis JD, Chen EZ, Baldassano RN, Otley AR, Griffiths AM, Lee D, et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn’s disease. Cell Host Microbe. 2015;18:489-500.

    Not in our library10.1016/j.chom.2015.09.008

  29. 29.

    He Q, Gao Y, Jie Z, Yu X, Laursen JM, Xiao L, et al. Two distinct metacommunities characterize the gut microbiota in Crohn’s disease patients. Gigascience. 2017;6:1-11.

    Not in our library10.1093/gigascience/gix050

  30. 30.
    Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases · 2019
    No notice
  31. 31.

    Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139:1844-54.e1.

    Not in our library10.1053/j.gastro.2010.08.049

  32. 32.
    Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment · 2012
    No notice
  33. 33.
    Non-Invasive Mapping of the Gastrointestinal Microbiota Identifies Children with Inflammatory Bowel Disease · 2012
    No notice
  34. 34.

    Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, et al. Gut microbiome development along the colorectal adenoma–carcinoma sequence. Nat Commun. 2015;6:6528.

    Not in our library10.1038/ncomms7528

  35. 35.

    Yu J, Feng Q, Wong SH, Zhang D, Liang QY, Qin Y, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut. 2017;66:70-78.

    Not in our library10.1136/gutjnl-2015-309800

  36. 36.
    Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing · 2016
    No notice
  37. 37.

    Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25:679-689.

    Not in our library10.1038/s41591-019-0406-6

  38. 38.

    Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med. 2019;25:667-678.

    Not in our library10.1038/s41591-019-0405-7

  39. 39.

    Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med. 2019;25:968-976.

    Not in our library10.1038/s41591-019-0458-7

  40. 40.

    Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012;6:320-329.

    Not in our library10.1038/ismej.2011.109

  41. 41.
    Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer · 2012
    No notice
  42. 42.
    Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions · 2016
    No notice
  43. 43.
    The gut microbiome in atherosclerotic cardiovascular disease · 2017
    No notice
  44. 44.
    Gut microbiota dysbiosis contributes to the development of hypertension · 2017
    No notice
  45. 45.

    Schubert AM, Rogers MAM, Ring C, Mogle J, Petrosino JP, Young VB, et al. Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls. MBio. 2014;5:e01021-e01014.

    Not in our library10.1128/mbio.01021-14

  46. 46.

    Vincent C, Stephens DA, Loo VG, Edens TJ, Behr MA, Dewar K, et al. Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection. Microbiome. 2013;1:18.

    Not in our library10.1186/2049-2618-1-18

  47. 47.
    Intestinal microbial communities associated with acute enteric infections and disease recovery · 2015
    No notice
  48. 48.

    Lozupone CA, Li M, Campbell TB, Flores SC, Linderman D, Gebert MJ, et al. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe. 2013;14:329-339.

    Not in our library10.1016/j.chom.2013.08.006

  49. 49.

    Dinh DM, Volpe GE, Duffalo C, Bhalchandra S, Tai AK, Kane AV, et al. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J Infect Dis. 2015;211:19-27.

    Not in our library10.1093/infdis/jiu409

  50. 50.
    Gut Microbiota Linked to Sexual Preference and HIV Infection · 2016
    No notice
  51. 51.

    Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513:59-64.

    Not in our library10.1038/nature13568

  52. 52.

    Zhang Z, Zhai H, Geng J, Yu R, Ren H, Fan H, et al. Large-scale survey of gut microbiota associated with MHE via 16S rRNA-based pyrosequencing. Am J Gastroenterol. 2013;108:1601-1611.

    Not in our library10.1038/ajg.2013.221

  53. 53.

    Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, et al. Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease. Cell Metab. 2017;25:1054-62.e5.

    Not in our library10.1016/j.cmet.2017.04.001

  54. 54.

    Hoyles L, Fernández-Real J-M, Federici M, Serino M, Abbott J, Charpentier J, et al. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat Med. 2018;24:1070-1080.

    Not in our library10.1038/s41591-018-0061-3

  55. 55.
    Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study · 2013
    No notice
  56. 56.

    Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology. 2013;57:601-609.

    Not in our library10.1002/hep.26093

  57. 57.
    Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients · 2017
    Corrected
  58. 58.

    Scheperjans F, Aho V, Pereira PAB, Koskinen K, Paulin L, Pekkonen E, et al. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord. 2015;30:350-358.

    Not in our library10.1002/mds.26069

  59. 59.
    Reduced Incidence of Prevotella and Other Fermenters in Intestinal Microflora of Autistic Children · 2013
    No notice
  60. 60.
    Comparison of Fecal Microbiota in Children with Autism Spectrum Disorders and Neurotypical Siblings in the Simons Simplex Collection · 2015
    No notice
  61. 61.

    Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500:541-546.

    Not in our library10.1038/nature12506

  62. 62.

    Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, et al. Human genetics shape the gut microbiome. Cell. 2014;159:789-799.

    Not in our library10.1016/j.cell.2014.09.053

  63. 63.

    Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480-484.

    Not in our library10.1038/nature07540

  64. 64.
    Analysis of the Gut Microbiota in the Old Order Amish and Its Relation to the Metabolic Syndrome · 2012
    No notice
  65. 65.

    Ross MC, Muzny DM, McCormick JB, Gibbs RA, Fisher-Hoch SP, Petrosino JF. 16S gut community of the Cameron County Hispanic Cohort. Microbiome. 2015;3:7.

    Not in our library10.1186/s40168-015-0072-y

  66. 66.

    Kushugulova A, Forslund SK, Costea PI, Kozhakhmetov S, Khassenbekova Z, Urazova M, et al. Metagenomic analysis of gut microbial communities from a Central Asian population. BMJ Open. 2018;8:e021682.

    Not in our library10.1136/bmjopen-2018-021682

  67. 67.

    Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498:99-103.

    Not in our library10.1038/nature12198

  68. 68.

    Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55-60.

    Not in our library10.1038/nature11450

  69. 69.
    phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data · 2013
    No notice
  70. 70.

    Bischl B, Lang M, Kotthoff L, Schiffner J. mlr: machine learning in R. J Mach. 2016;17:1-5.

    Not in our library

  71. 71.

    Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104:13780-13785.

    Not in our library10.1073/pnas.0706625104

  72. 72.

    Pasolli E, Schiffer L, Manghi P, Renson A, Obenchain V, Truong DT, et al. Accessible, curated metagenomic data through ExperimentHub. Nat Methods. 2017;14:1023-1024.

    Not in our library10.1038/nmeth.4468

  73. 73.

    Hawinkel S, Mattiello F, Bijnens L, Thas O. A broken promise: microbiome differential abundance methods do not control the false discovery rate. Brief Bioinform. 2019;20:210-221.

    Not in our library10.1093/bib/bbx104

  74. 74.

    Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Series B Stat Methodol. 1996;58:267-288.

    Not in our library

  75. 75.

    Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc Series B Stat Methodol. 2005;67(2):301–20 Wiley Online Library.

    Not in our library

  76. 76.

    Ho TK. Random decision forests. Proceedings of 3rd International Conference on Document Analysis and Recognition. 1995;278-282.

    Not in our library

  77. 77.

    Deloris Alexander A, Orcutt RP, Henry JC, Baker J, Bissahoyo AC, Threadgill DW. Quantitative PCR assays for mouse enteric flora reveal strain-dependent differences in composition that are influenced by the microenvironment. Mamm Genome. 2006;17:1093-1104.

    Not in our library10.1007/s00335-006-0063-1

  78. 78.

    Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65:740-748.

    Not in our library10.1136/gutjnl-2015-310376

  79. 79.
    Proton pump inhibitors alter the composition of the gut microbiota · 2015
    No notice
  80. 80.

    Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining, inference, and prediction. New York: Springer; 2009

    Not in our library

  81. 81.

    Smialowski P, Frishman D, Kramer S. Pitfalls of supervised feature selection. Bioinformatics. 2010;26:440-443.

    Not in our library10.1093/bioinformatics/btp621

  82. 82.

    Roberts DR, Bahn V, Ciuti S, Boyce MS, Elith J, Guillera-Arroita G, et al. Cross-validation strategies for data with temporal, spatial, hierarchical, or phylogenetic structure. Ecography. 2017;40:913-929.

    Not in our library10.1111/ecog.02881

  83. 83.

    Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol Am Soc Microbiol. 2007;73:5261-5267.

    Not in our library10.1128/aem.00062-07

  84. 84.

    Truong DT, Franzosa EA, Tickle TL, Scholz M, Weingart G, Pasolli E, et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods. 2015;12:902-903.

    Not in our library10.1038/nmeth.3589

  85. 85.
    Microbial abundance, activity and population genomic profiling with mOTUs2 · 2019
    No notice
  86. 86.

    Franzosa EA, McIver LJ, Rahnavard G, Thompson LR, Schirmer M, Weingart G, et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods. 2018;15:962-968.

    Not in our library10.1038/s41592-018-0176-y

  87. 87.
    eggNOG 4.5: a hierarchical orthology framework with improved functional annotations for eukaryotic, prokaryotic and viral sequences · 2015
    No notice
  88. 88.

    Lozupone CA, Stombaugh J, Gonzalez A, Ackermann G, Wendel D, Vázquez-Baeza Y, et al. Meta-analyses of studies of the human microbiota. Genome Res. 2013;23:1704-1714.

    Not in our library10.1101/gr.151803.112

  89. 89.

    Sinha R, The Microbiome Quality Control Project Consortium, Abu-Ali G, Vogtmann E, Fodor AA, Ren B, et al. Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. Nat Biotechnol. 2017;35:1077-1086.

    Not in our library10.1038/nbt.3981

  90. 90.

    Costea PI, Zeller G, Sunagawa S, Pelletier E, Alberti A, Levenez F, et al. Towards standards for human fecal sample processing in metagenomic studies. Nat Biotechnol. 2017;35:1069-1076.

    Not in our library10.1038/nbt.3960

  91. 91.

    Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ. 1994;309:1351-1355.

    Not in our library10.1136/bmj.309.6965.1351

  92. 92.

    Olesen SW, Alm EJ. Dysbiosis is not an answer. Nat Microbiol. 2016;1:16228.

    Not in our library10.1038/nmicrobiol.2016.228

  93. 93.

    Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163:1079-1094.

    Not in our library10.1016/j.cell.2015.11.001

  94. 94.

    Schirmer M, Smeekens SP, Vlamakis H, Jaeger M, Oosting M, Franzosa EA, et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell. 2016;167:1897.

    Not in our library10.1016/j.cell.2016.11.046

  95. 95.

    Xie H, Guo R, Zhong H, Feng Q, Lan Z, Qin B, et al. Shotgun metagenomics of 250 adult twins reveals genetic and environmental impacts on the gut microbiome. Cell Syst. 2016;3:572-84.e3.

    Not in our library10.1016/j.cels.2016.10.004

  96. 96.

    Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91:854-862.

    Not in our library10.1002/1097-0142(20010215)91:4<854::aid-cncr1073>3.0.co;2-z

  97. 97.

    Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut. 2006;55:205-211.

    Not in our library10.1136/gut.2005.073817

  98. 98.

    Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581-583.

    Not in our library10.1038/nmeth.3869

  99. 99.

    Cani PD. Gut microbiota - at the intersection of everything? Nat Rev Gastroenterol Hepatol. 2017;14:321-322.

    Not in our library10.1038/nrgastro.2017.54

  100. 100.

    Yilmaz P, Kottmann R, Field D, Knight R, Cole JR, Amaral-Zettler L, et al. Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications. Nat Biotechnol. 2011;29:415-420.

    Not in our library10.1038/nbt.1823

  101. 101.

    Yu J, Zhao L, Zhao R, Long X, Coker OO, Sung JJY. The role of Parvimonas micra in intestinal tumorigenesis in germ-free and conventional APCmin/+ mice. J Clin Orthod. 2019;37:531.

    Not in our library

  102. 102.

    Horvath A, Rainer F, Bashir M, Leber B, Schmerboeck B, Klymiuk I, et al. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis. Sci Rep. 2019;9:12000.

    Not in our library10.1038/s41598-019-48352-5

  103. 103.

    Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14:195-206.

    Not in our library10.1016/j.chom.2013.07.012

  104. 104.

    Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut. 2003;52:79-83.

    Not in our library10.1136/gut.52.1.79

  105. 105.

    Salazar G, Paoli L, Alberti A, Huerta-Cepas J, Ruscheweyh H-J, Cuenca M, et al. Gene expression changes and community turnover differentially shape the global ocean metatranscriptome. Cell. 2019;179:1068-83.e21.

    Not in our library10.1016/j.cell.2019.10.014

  106. 106.

    Coelho LP, Alves R, Monteiro P, Huerta-Cepas J, Freitas AT, Bork P. NG-meta-profiler: fast processing of metagenomes using NGLess, a domain-specific language. Microbiome. 2019;7:84.

    Not in our library10.1186/s40168-019-0684-8

  107. 107.

    Kultima JR, Coelho LP, Forslund K, Huerta-Cepas J, Li SS, Driessen M, et al. MOCAT2: a metagenomic assembly, annotation and profiling framework. Bioinformatics. 2016;32:2520-2523.

    Not in our library10.1093/bioinformatics/btw183

  108. 108.

    Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S, et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol. 2014;32:834-841.

    Not in our library10.1038/nbt.2942

  109. 109.

    Fox J, Weisberg S. An R companion to applied regression. Thousand Oaks: SAGE Publications; 2018.

    Not in our library

  110. 110.
    Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox · 2021
    No notice
  111. 111.
    Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox · 2021
    No notice
  112. 112.
    Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox · 2021
    No notice
  113. 113.
    Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox · 2021
    No notice

Cited by papers we hold 10

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.